Mohamed Osman, MD
Interventional Cardiology · Plantation, FLNPI 1730103961
Payments from drug & device makers
Across 162 payments — averaging $138.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Impulse Dynamics (USA) Inc.$9K
- Penumbra, Inc.$3K
- Abbott$2K
- Edwards Lifesciences$2K
- Boston Scientific$2K
- Inari Medical, Inc.$1K
- plus $3K from 27 others
What the payments were for
- Travel & lodging$5,78344%
- Food & beverage$7,36556%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Impulse Dynamics (USA) Inc. | 6 | $9,252 |
| Penumbra, Inc. | 11 | $3,408 |
| Abbott | 30 | $2,058 |
| Edwards Lifesciences | 11 | $1,852 |
| Boston Scientific | 19 | $1,703 |
| Inari Medical, Inc. | 13 | $1,055 |
| Medtronic(2 entities) | 14 | $769 |
| Cardiovascular Systems Inc. | 4 | $600 |
| Atricure, Inc. | 2 | $237 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $152 |
| Philips North America LLC | 3 | $140 |
| Stryker | 4 | $137 |
| Pfizer | 1 | $113 |
| Curonix LLC | 1 | $91 |
| Lilly USA, LLC | 2 | $85 |
| Argon Medical Devices, Inc. | 1 | $75 |
| Cook Medical LLC | 3 | $73 |
| Cardiva Medical, Inc. | 3 | $73 |
| Acist Medical Systems, Inc. | 4 | $72 |
| E.r. Squibb & Sons, L.L.C. | 3 | $61 |
| Heartflow, Inc. | 2 | $47 |
| Shockwave Medical, Inc | 2 | $47 |
| Biotronik Inc. | 1 | $44 |
| Novartis | 2 | $41 |
| Cardinal Health 200 LLC | 2 | $36 |
| Abiomed | 1 | $29 |
| Humacyte Global, Inc. | 1 | $25 |
| Johnson & Johnson | 2 | $25 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
| Irhythm Technologies, Inc. | 1 | $21 |
| Terumo Medical Corporation | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| W. L. Gore & Associates, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,108
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,477
- Indigo$1,231
- Watchman$956
- TRICLIP$868
- FLOWTRIEVER CATHETER, S$666
- CT THROMBECTOMY SYSTEM KIT$666
- Coronary Orbital Atherectomy System$473
- GENERAL PAIN MANAGEMENT$303
- CardioMEMS HF System$264
- CoreValve Evolut$215
- GENERAL VASCULAR ACCESS$186
- NAVITOR$161
- Micra$158
- COBALT DR MRI SURESCAN$114
- VYNDAQEL$113
- LUX-Dx Insertable Cardiac Monitor$108
- (6577) Visions 014$101
How this compares
$22,399 in reported general payments places this provider in the 65th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 97 | $86,991 |
| EntrestoSacubitril/Valsartan | 43 | $54,074 |
| FarxigaDapagliflozin Propanediol | 26 | $28,801 |
| Repatha SureclickEvolocumab | 22 | $19,352 |
| ClopidogrelClopidogrel Bisulfate | 181 | $1,739 |
| Atorvastatin Calcium | 89 | $676 |
| Metoprolol Succinate | 35 | $554 |
| Valsartan | 18 | $533 |
| Losartan Potassium | 44 | $345 |
| Rosuvastatin Calcium | 22 | $307 |
| Carvedilol | 47 | $306 |
| Metoprolol Tartrate | 72 | $283 |
| Levothyroxine Sodium | 25 | $247 |
| Furosemide | 32 | $236 |
| Potassium Chloride | 18 | $223 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $113 | $86,99197 claims |
| NovartisEntresto | $41 | $54,07443 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Plantation
- Dominick AngiolilloJacksonville$4M
- Douglas SpriggsClearwater$3.2M
- Rakesh PrashadOcala$3.1M
- Aldo Martinez FleitesMiami Lakes$2.2M
- Rohit AminPensacola$2M
- Roberto CubedduNaples$2M
- Arthur LeeGainesville$2M
- Ruby SatpathyJacksonville$1.8M
- Santhosh MathewsBradenton$1.7M
- Pedro Martinez-ClarkMiami$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.